Topical steroids in the current clinical practice

2017

Vestnik Dermatologii i Venerologii, Vol 0, Iss 4, Pp 83-88 (2017)

The article discusses issues related to current criteria for selection of glucocorticosteroids for external use as the basic therapy for a great number of allergic and inflammatory skin diseases. The authors emphasize that non-fluorinated GCSs having the best efficacy-to-safety ratio must be the drugs of first choice. The article provides data on a positive clinical experience of using a non-halogenated glucocorticosteroid for external use - hydrocortisone 17-butyrate (Laticort) - for treatment of steroid-sensitive dermatoses in children and adults. The drug has a high anti-inflammatory action and minimum risk of the development of side effects, which is sufficient for using it in sensitive areas of skin (face, neck, folds, genitals) both in children and in adults. The availability of three forms of the drug (solution, cream and ointment) ensures the expedience and convenience of its application at any stage of the inflammatory process and for any localization.

article

English
Russian

State Scientific Center of Dermatovenereology and Cosmetology, 2017.

наружные глюкокортикостероиды, стероидочувствительные дерматозы, гидрокортизон 17-бутирата (латикорт), glucocorticosteroids for external use, steroid-sensitive dermatoses, hydrocortisone 17-butyrate (laticort), Dermatology, RL1-803